Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China.

Shiyi GongHao HuKun ZhaoTing Yang

Published in: International journal of chronic obstructive pulmonary disease (2021)

This study found that dual bronchodilator IND/GLY is cost-effective for stable COPD treatment in China from Chinese payer's perspective.

Keyphrases